Scale AI vs a2z Radiology AI
Side-by-side comparison of AI visibility scores, market position, and capabilities
AI training data platform with $14B valuation; human-labeled datasets for OpenAI, Anthropic, and DOD plus LLM evaluation tools as critical AI infrastructure competing with Appen.
About
Scale AI is an AI data platform providing data labeling, data curation, and AI evaluation services that power the training and fine-tuning of AI models for major technology companies, autonomous vehicle developers, and government agencies. Founded in 2016 by Alexandr Wang and Lucy Guo in San Francisco, Scale AI has raised approximately $1.5 billion at a $14 billion valuation and generates substantial revenue from contracts with AI labs (OpenAI, Anthropic, Meta AI), government defense clients (US Department of Defense), and enterprise AI teams needing high-quality training data.\n\nScale AI's core service is human-in-the-loop data labeling — providing labeled datasets (annotated images, transcribed and labeled conversations, validated code outputs) that AI models need for training and evaluation. Scale's platform combines AI-assisted pre-labeling with human quality verification, reducing the cost of producing labeled data while maintaining accuracy standards. Scale Spellbook provides API-based LLM evaluation and comparison tools. Scale's Government division has grown significantly, providing AI evaluation and training data services to US defense and intelligence agencies.\n\nIn 2025, Scale AI is one of the most strategically positioned companies in the AI infrastructure stack — as AI labs compete to train frontier models, the quality and volume of training data has become a critical competitive variable. Scale's defense contracts have expanded significantly under the Biden and Trump administrations'AI strategy initiatives. Scale competes with Appen, Surge AI, and cloud provider-native labeling services for AI training data. The 2025 strategy focuses on expanding its government and defense business, launching Scale's Frontier Data for synthetic data generation to supplement human-labeled data, and growing its enterprise AI deployment services for Fortune 500 companies building production AI systems.
a2z Radiology AI raised $20M in 2025 for its whole-body AI that simultaneously screens for 24+ conditions across CT scans — from incidental cancers to cardiovascular risk — in a single automated read.
About
a2z Radiology AI has developed a whole-body CT analysis platform that simultaneously screens for over 24 medical conditions across a single CT scan, including incidental cancers, coronary artery disease, aortic aneurysm, bone density loss, and organ abnormalities. The AI acts as a second reader that radiologists can use to catch incidental findings that fall outside the primary reason for a scan — a major source of missed diagnoses.
AI Visibility Head-to-Head
Key Details
Capabilities & Ecosystem
Also Compare
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.